Acetylcysteine
Acetylcysteine is a medicine used in two main ways: as an antidote to prevent or lessen liver injury after an acetaminophen overdose, and as an add-on treatment to thin thick, sticky mucus in lung and airway conditions.
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 7 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
How we combine label and product data →
Acetylcysteine is the standard antidote for acetaminophen (Tylenol) overdose, shielding the liver by restoring glutathione, its natural protector, and possibly neutralizing the toxic by-product directly. Inhaled, it is an older add-on that thins thick mucus, and it has been around since about 1982 and is available generically. Most people handle it fairly well, with nausea, vomiting, flushing or an itchy rash the usual complaints. The injection can trigger a serious allergic reaction, usually soon after it starts, so staff give and watch it closely, especially in people with asthma. It is time-sensitive, working best within 8 to 10 hours of the overdose, so seek help even before symptoms.
Clinical pearls
- Doctors decide whether to treat using an acetaminophen blood level drawn at least 4 hours after the overdose.
- Inhaled, it loosens mucus so the volume can rise, and coughing it up or suction keeps the airway clear.
- If you have asthma, say so before either form, because airway tightening can worsen and treatment may need to stop.
- After the injection, pumping and discarding breast milk for 30 hours may be considered, since no human milk data exist.
Patient information guide — a plain-language walkthrough of Acetylcysteine, written from its FDA label.
What Acetylcysteine is used for
▾
Acetylcysteine is used for different purposes depending on the product.
- Acetadote and Acetylcysteine Injection (intravenous): antidote to prevent or lessen liver injury after acetaminophen overdose, from a single large ingestion or repeated higher-than-safe doses. Acetadote is labeled for adults and children weighing 5 kg or more.
- Acetylcysteine solution (oral and inhalation): antidote for acetaminophen overdose when given by mouth.
- Acetylcysteine solution and inhalant: add-on therapy for thick, sticky or dried mucus.
- Lung conditions listed: chronic emphysema, emphysema with bronchitis, chronic asthmatic bronchitis, tuberculosis, bronchiectasis and primary amyloidosis of the lung.
- Acute lung conditions listed: pneumonia, bronchitis and tracheobronchitis.
- Other uses: cystic fibrosis lung complications, tracheostomy care, complications after surgery, use during anesthesia, post-traumatic chest conditions and atelectasis (collapsed lung areas) from mucus blockage.
- Diagnostic bronchial studies: bronchograms, bronchospirometry and bronchial wedge catheterization.
How Acetylcysteine works
▾
Too much acetaminophen overwhelms the liver's usual safe disposal routes. More of the drug is turned into a harmful by-product, which uses up the liver's glutathione and then damages liver cells.
Acetylcysteine likely protects the liver by maintaining or restoring glutathione, or by helping detoxify the harmful by-product. It works best when started early, mainly within 8 to 10 hours.
Acetylcysteine dosage
▾
The way acetylcysteine is given depends on the product.
- Injection (Acetadote, Acetylcysteine Injection): given into a vein by healthcare staff, starting with a loading dose. Treatment may continue for about 20 to 21 hours in some situations.
- Inhalation solution: nebulized through a face mask, mouthpiece or tracheostomy, usually 3 to 4 times a day for most patients. A tent or croupette is sometimes used, with the method tailored to the patient.
- The 20% solution may be diluted. The 10% solution can be used undiluted.
- Opened vials have no preservative. Refrigerate the remainder and use it for inhalation within 96 hours.
Follow your prescriber and the product label.
Dosing details from the FDA-approved label
From the Acetylcysteine prescribing information (“Dosage and Administration”). Doses are set by your prescriber for your product, condition, kidney function and age — never change a dose on your own.
- Acute acetaminophen ingestion (Acetadote) - total dosage
- 300 mg/kg given intravenously as either 3 separate doses infused over a total of 21 hours OR 2 separate doses infused over a total of 20 hours
- Patients 40 kg or less should receive the three-bag regimen; for patients weighing 41 kg or greater, the three-bag regimen may be preferred for those with early signs of severe liver injury or a large acetaminophen ingestion
- Acute acetaminophen ingestion - time of ingestion unknown
- Administer a loading dose of ACETADOTE immediately
- Obtain an acetaminophen concentration to determine need for continued treatment
- Acute acetaminophen ingestion - acetaminophen concentration cannot be obtained (or is unavailable or uninterpretable) within the 8-hour interval after ingestion, or clinical evidence of acetaminophen toxicity
- Administer a loading dose of ACETADOTE immediately and continue treatment for a total of two doses over 20 hours or three doses over 21 hours
- Acute acetaminophen ingestion - patient presents more than 8 hours after ingestion and time of ingestion is known
- Administer a loading dose of ACETADOTE immediately
- Obtain acetaminophen concentration to determine need for continued treatment
- Acute acetaminophen ingestion - patient presents less than 8 hours after ingestion, time of ingestion known and acetaminophen concentration known
- Use the revised Rumack-Matthew nomogram (Figure 1) to determine whether or not to initiate treatment with ACETADOTE
- Acute acetaminophen ingestion (acetylcysteine injection, generic label) - total dosage
- 300 mg/kg given intravenously as 3 separate doses
- Total recommended infusion time for 3 doses is 21 hours
- Adult and pediatric dosage; weight-based dosage and dilution in Full Prescribing Information
- Repeated supratherapeutic acetaminophen ingestion
- Obtain acetaminophen concentration and other laboratory tests to guide treatment
- Rumack-Matthew nomogram does not apply
Read the label’s full dosing text
DOSAGE AND ADMINISTRATION General Acetylcysteine solution is available in rubber stoppered glass vials containing 4 or 30 mL. The 20% solution may be diluted to a lesser concentration with either sodium chloride for injection, sodium chloride for inhalation, sterile water for injection, or sterile water for inhalation. The 10% solution may be used undiluted. Acetylcysteine solution does not contain an antimicrobial agent, and care must be taken to minimize contamination of the sterile solution. If only a portion of the solution in a vial is used, store the remainder in a refrigerator and use for inhalation only within 96 hours. NEBULIZATION—FACE MASK, MOUTH PIECE, TRACHEOSTOMY When nebulized into a face mask, mouth piece, or tracheostomy, 1 to 10 mL of the 20% solution or 2 to 20 mL of the 10% solution may be given every 2 to 6 hours; the recommended dose for most patients is 3 to 5 mL of the 20% solution or 6 to 10 mL of the 10% solution 3 to 4 times a day. NEBULIZATION TENT, CROUPETTE In special circumstances it may be necessary to nebulize into a tent or croupette, and this method of use must be individualized to take into account the available equipment and the patient's particular needs. This form of administration requires very large volumes of the solution, occasionally as much as 300 mL during a single treatment period. If a tent or croupette must be used, the recommended dose is the volume of acetylcysteine solution (using 10% or 20%) that will maintain a very heavy mist in the tent or croupette for the desired period. Administration for intermittent or continuous prolonged periods, including overnight, may be desirable. DIRECT INSTILLATION When used by direct instillation, 1 to 2 mL of a 10% to 20% solution may be given as often as every hour. When used for the routine nursing care of patients with tracheostomy, 1 to 2 mL of a 10% to 20% solution may be given every 1 to 4 hours by instillation into the tracheostomy. Acetylcysteine solution may be introduced directly into a particular segment of the bronchopulmonary tree by inserting (under local anesthesia and direct vision) a small plastic catheter into the trachea. Two to 5 mL of the 20% solution may then be instilled by means of a syringe connected to the catheter. Acetylcysteine solution may also be given through a percutaneous intratracheal catheter.
Excerpted — the section continues on the label. Read the full Dosage and Administration section on DailyMed →
Acetylcysteine side effects
▾
Common side effects
- Rash
- Hives (urticaria) or facial flushing
- Itching (pruritus)
- Nausea
- Vomiting
- Fast heartbeat (tachycardia)
When to get medical help
- Get emergency help for trouble breathing, wheezing, throat tightness, low blood pressure or swelling. These can be signs of a serious allergic reaction.
- Tell your care team right away if you have a rash, hives or itching that goes beyond mild flushing.
- If you have asthma and develop worsening wheezing or bronchospasm (airway tightening), tell your care team immediately.
- With the injection, too much fluid can cause low sodium, seizures and death. Staff adjust the volume for people under 40 kg or on fluid limits.
- With oral use for overdose, tell your care team about widespread hives or other allergic symptoms.
- If liver failure causes confusion (encephalopathy), tell your care team, since treatment may need to stop.
Most side effects are allergy-type skin reactions, especially with the injection.
- Rash
- Hives or facial flushing
- Itching
- Nausea and vomiting
- Fast heartbeat
Seek help right away for wheezing, shortness of breath, low blood pressure, swelling or throat tightness. These can signal a serious allergic reaction.
Acetylcysteine warnings and precautions
▾
- Serious allergic reactions can happen with the injection, usually soon after the infusion starts. Fatal anaphylaxis has been reported after approval.
- People with asthma or a history of bronchospasm need close monitoring.
- The injection can cause fluid overload, leading to low sodium, seizures and death. The volume is reduced for people under 40 kg or on fluid restriction.
- Inhaled use can increase the volume of loosened secretions, so keep the airway clear.
- Oral use for overdose has rarely caused widespread hives.
- If encephalopathy from liver failure appears, treatment should be stopped.
Acetylcysteine interactions
▾
No drug interaction studies have been conducted with acetylcysteine, so specific interactions are not described.
Interactions listed in the FDA-approved label
From the Acetylcysteine prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.
- Drug-drug interactions (any): No drug-drug interaction studies have been conducted.
Read the label’s full interactions text
Drug Interactions Drug stability and safety of acetylcysteine when mixed with other drugs in a nebulizer have not been established.
Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.
Before taking Acetylcysteine
▾
- Do not use the injection if you have had an allergic reaction to acetylcysteine.
- Tell your care team if you have asthma or have had bronchospasm.
- Tell your care team if you are on fluid restriction or weigh less than 40 kg.
- Pregnancy: acetylcysteine crosses the placenta. Delaying overdose treatment may raise the risk to mother and baby.
- Breastfeeding: there are no milk data. Pumping and discarding milk for 30 hours after the injection may be considered.
- Children: injection use in children 5 kg and over is based on clinical practice.
- Severe liver damage (cirrhosis) slows how fast the body clears acetylcysteine.
Acetylcysteine overdose
▾
Too much acetylcysteine can cause fatal or life-threatening problems, including anaphylaxis, brain swelling (cerebral edema) and hemolytic-uremic syndrome (HUS), which involves red blood cell breakdown and kidney injury. Stop acetylcysteine if overdose is suspected. Call Poison Control at 1-800-222-1222 for guidance, including whether hemodialysis is appropriate.
What Acetylcysteine does in the body
▾
Acetylcysteine has been shown to reduce the extent of liver injury after acetaminophen overdose. Benefit is seen mainly when treatment starts within 8 to 10 hours. Efficacy drops steadily after 8 hours. Treatment started 15 to 24 hours after ingestion has limited benefit, but it should not be withheld because the reported time of ingestion may be wrong.
How your body processes Acetylcysteine
▾
After an intravenous dose, acetylcysteine levels fall with a mean half-life of about 5.6 hours in adults. In newborns it is longer, about 11 hours. About 83% is bound to proteins in the blood. Kidney clearance accounts for about 30% of total clearance. In people with severe liver cirrhosis, the half-life rises by about 80%.
How to store Acetylcysteine
▾
Store unopened vials at 20 ° - 25 °C (68 ° - 77 °F); excursions permitted to 15 °- 30 °C (59 ° – 86 °F) (see USP Controlled Room Temperature). store the remaining undiluted portion in a refrigerator and use within 96 hours.
Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI →
Acetylcysteine: pharmacist answers to common questions
Quick, plain-English answers to the questions patients ask most about Acetylcysteine — the kind of thing our pharmacy team would talk through with you at the counter.
What is acetylcysteine used for?
▾
How is it given?
▾
What side effects should I expect?
▾
When should I get help right away?
▾
Is it safe in pregnancy or while breastfeeding?
▾
Does it interact with other medicines?
▾
Is Acetylcysteine available over the counter?
▾
When was Acetylcysteine first available?
▾
Who makes Acetylcysteine?
▾
Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI →
More about Acetylcysteine on HelloPharmacist
Acetylcysteine forms and strengths (how it comes)
Acetylcysteine is available in 3 forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Injection
How this form is used
- Acetadote is an antidote to prevent or lessen liver injury after acetaminophen overdose in adults and children 5 kg or more.
- Acetylcysteine Injection is used to prevent or lessen liver injury after a potentially toxic acetaminophen ingestion.
- Acetadote is given into a vein, starting with a loading dose.
- Acetylcysteine Injection is given into a vein, often after an acetaminophen blood level is checked at least 4 hours after ingestion.
- Acetylcysteine Injection volume is reduced for patients under 40 kg or on fluid restriction.
Inhalation solution (nebulizer)
How this form is used
- Acetylcysteine solution is add-on therapy for thick, abnormal mucus in chronic and acute lung disease, cystic fibrosis complications, tracheostomy care and atelectasis.
- Acetylcysteine solution is also used before certain diagnostic bronchial studies.
- Acetylcysteine given by mouth is an antidote for acetaminophen overdose.
- Acetylcysteine 20% solution may be diluted, and the 10% solution may be used undiluted.
- Acetylcysteine is nebulized through a face mask, mouthpiece or tracheostomy, usually 3 to 4 times a day for most patients.
- Acetylcysteine has no preservative, so an opened vial's remainder should be refrigerated and used for inhalation within 96 hours.
Inhaler
How this form is used
- Acetylcysteine inhalant is add-on therapy for thick, abnormal mucus in lung conditions.
- Acetylcysteine given by mouth is an antidote for acetaminophen overdose.
- Acetylcysteine inhalant is supplied in vials, and the 20% strength may be diluted.
- Acetylcysteine inhalant is nebulized through a face mask, mouthpiece or tracheostomy.
- Acetylcysteine inhalant leftovers should be refrigerated and used within 96 hours.
Acetylcysteine on the U.S. market: products, makers and brands
How Acetylcysteine appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
32 companies list 85 Acetylcysteine product records with the FDA, mostly as injection, inhalation solution (nebulizer), inhaler; the earliest marketing or approval year on record is 1963. Brand names on the directory include Acetadote; the rest are generics.
FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
Also listed with the FDA, not a patient dose form: Powder (19) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
How widely Acetylcysteine is used (Medicaid data)
A general measure of how commonly Acetylcysteine is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.
Think of this as a proxy for how widely Acetylcysteine is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.
How commonly is Acetylcysteine prescribed? Of the 1,601 medications we measure, Acetylcysteine ranks #850 by Medicaid prescriptions — more than 47% of them.
Utilization by Acetylcysteine product
Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.
acetylcysteine 200 MG/ML Inhalation Solution Most dispensed
Summed across the 9 of 28 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 307719
acetylcysteine 100 MG/ML Inhalation Solution
Summed across the 6 of 17 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 307718
30 ML acetylcysteine 200 MG/ML Injection
Summed across the 5 of 26 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 465377
Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.
Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Acetylcysteine, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 20 of 71 listed Acetylcysteine NDCs with Medicaid activity.
Compare Acetylcysteine products
A representative set of FDA-listed product records for Acetylcysteine — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Inhalation solution (nebulizer) | ||||
| 100 mg/mL | Respiratory (inhalation) | Cameron Pharmaceuticals | ANDA | View NDC → |
| 200 mg/mL | Respiratory (inhalation) | Cameron Pharmaceuticals | ANDA | View NDC → |
| 200 mg/mL | Oral; Respiratory (inhalation) | Exela Pharma Sciences, LLC | ANDA | View NDC → |
| 100 mg/mL | Oral, Respiratory (inhalation) | Fresenius Kabi USA, LLC × 3 listings | ANDA | View NDC → |
| 100 mg/mL | Oral; Respiratory (inhalation) | Fresenius Kabi USA, LLC × 3 listings | ANDA | View NDC → |
| 200 mg/mL | Oral, Respiratory (inhalation) | Fresenius Kabi USA, LLC × 5 listings | ANDA | View NDC → |
| 200 mg/mL | Oral; Respiratory (inhalation) | Fresenius Kabi USA, LLC × 3 listings | ANDA | View NDC → |
| 100 mg/mL | Oral, Respiratory (inhalation) | Hospira, Inc. | ANDA | View NDC → |
| 100 mg/mL | Oral; Respiratory (inhalation) | Hospira, Inc. | ANDA | View NDC → |
| 200 mg/mL | Oral, Respiratory (inhalation) | Hospira, Inc. | ANDA | View NDC → |
| 200 mg/mL | Oral; Respiratory (inhalation) | Hospira, Inc. | ANDA | View NDC → |
| 100 mg/mL | Respiratory (inhalation) | Somerset Therapeutics, LLC | ANDA | View NDC → |
| 200 mg/mL | Respiratory (inhalation) | Somerset Therapeutics, LLC × 2 listings | ANDA | View NDC → |
| 💊Inhaler | ||||
| 100 mg/mL | Respiratory (inhalation) | American Regent, Inc. × 4 listings | ANDA | View NDC → |
| 200 mg/mL | Respiratory (inhalation) | American Regent, Inc. × 5 listings | ANDA | View NDC → |
| 100 mg/mL | Respiratory (inhalation) | Cardinal Health 107, LLC | ANDA | View NDC → |
| 100 mg/mL | Oral; Respiratory (inhalation) | Cardinal Health 107, LLC | ANDA | View NDC → |
| 200 mg/mL | Respiratory (inhalation) | Cardinal Health 107, LLC | ANDA | View NDC → |
| 200 mg/mL | Oral; Respiratory (inhalation) | Cardinal Health 107, LLC | ANDA | View NDC → |
| 💊Injection | ||||
| 200 mg/mL | Intravenous | Akorn | ANDA | View NDC → |
| 200 mg/mL | Intravenous | Almaject, Inc. × 2 listings | ANDA | View NDC → |
| 6 g/30 mL | Intravenous | AuroMedics Pharma LLC | ANDA | View NDC → |
| 200 mg/mL | Intravenous | Cumberland Pharmaceuticals Inc. × 2 listings | NDA | View NDC → |
| 6 g/30 mL | Intravenous | Eugia US LLC × 2 listings | ANDA | View NDC → |
| 200 mg/mL | Intravenous | Exela Pharma Sciences, LLC | ANDA | View NDC → |
| 200 mg/mL | Intravenous | Fresenius Kabi USA, LLC × 2 listings | ANDA | View NDC → |
| 200 mg/mL | Intravenous | Glenmark Pharmaceuticals Inc., USA | ANDA | View NDC → |
| 200 mg/mL | Intravenous | Hikma Pharmaceuticals USA Inc. | ANDA | View NDC → |
| 200 mg/mL | Intravenous | Indoco Remedies Limited | ANDA | View NDC → |
| 200 mg/mL | Intravenous | Onesource Specialty Pharma Limited | ANDA | View NDC → |
| 200 mg/mL | Intravenous | Padagis US LLC × 2 listings | NDA AUTHORIZED GENERIC | View NDC → |
| 200 mg/mL | Intravenous | Padagis US LLC | NDA | View NDC → |
| 200 mg/mL | Intravenous | Sagent Pharmaceuticals × 5 listings | ANDA | View NDC → |
| 200 mg/mL | Intravenous | Somerset Therapeutics, LLC | ANDA | View NDC → |
| 200 mg/mL | Intravenous | Stelis Biopharma Limited | ANDA | View NDC → |
| 200 mg/mL | Intravenous | Xellia Pharmaceuticals USA LLC | ANDA | View NDC → |
| 200 mg/mL | Intravenous | Zydus Lifesciences Limited | ANDA | View NDC → |
| 200 mg/mL | Intravenous | Zydus Pharmaceuticals (USA) Inc. | ANDA | View NDC → |
| 200 mg/mL | Intravenous | Zydus Pharmaceuticals USA Inc. | ANDA | View NDC → |
| 💊Bulk drug substance | ||||
| 1 kg/kg | — | F.I.S. Fabbrica Italiana Sintetici S.P.A. | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Fujian South Pharmaceutical Co., Ltd. | BULK INGREDIENT | View NDC → |
| 1 g/g | — | Maeda Inc | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Moehs Catalana SL | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Nippon Rika Co., Ltd. × 2 listings | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | PharmaZell GmbH × 6 listings | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | PharmaZell GmbH × 4 listings | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING | View NDC → |
| 1 kg/kg | — | Professional Compounding Centers of America dba PCCA | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING | View NDC → |
| 1 kg/kg | — | Spectrum Laboratory Products, Inc. | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Willow Birch Pharma, LLC | BULK INGREDIENT | View NDC → |
Showing 85 of 85 products — FDA National Drug Code Directory. See every product, package size and price: browse all 85 Acetylcysteine NDCs →
Acetylcysteine side effects reported to the FDA (FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Acetylcysteine — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Acetylcysteine in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
Acetylcysteine FDA approval history
How Acetylcysteine went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
Acetylcysteine recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
The FDA’s enforcement reports list one Acetylcysteine recall since July 2021, covering 2 product listings. It is still ongoing. A recall names specific lots from one company, so check the lot number on your own bottle rather than assuming every product is affected; your pharmacist can check whether your supply came from an affected lot.
- ACETYLCYSTEINE SOLUTION, USP, 20% (200 mg/mL), packaged in a) 4 mL Vial NOT FOR INJECTION (NDC 0517-7604-01), and b) 25x4 mL Vials NOT FOR INJECTION (NDC 0517-7604-25), Rx only, AMERICAN REGENT, INC.… Lots: Lot #: 24426, Exp. Date: 11/30/2026; 25220, Exp. Date: 5/31/2027. FDA record D-0797-2026 →
- ACETYLCYSTEINE SOLUTION, USP, 10% (100 mg/mL), packaged in a) 4 mL Vial NOT FOR INJECTION (NDC 0517-7504-01), and b) 25x4 mL Vials NOT FOR INJECTION (NDC 0517-7504-25), Rx Only, AMERICAN REGENT, INC.… Lots: Lot #: 24418, Exp. Date: 11/30/2026; 25131, Exp. Date: 3/31/2027; 25349, Exp. Date: 8/31/2027 FDA record D-0796-2026 →
Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Sep 24, 2026.
RxNorm Concept Web — From Ingredient to Every Form and Strength
This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.
RxCUI 197 5 dose forms · 9 strengths
-
Dose form (SCDF) Inhalation Solution RxCUI 2108211In current FDA listings -
Dose form (SCDF) Injection RxCUI 1742774In current FDA listingsClinical drug / strength (SCD) 30 ML acetylcysteine 200 MG/MLRxCUI 465377 -
Dose form (SCDF) Ophthalmic Solution RxCUI 377405No current FDA listingClinical drug / strength (SCD) 25 MG/MLRxCUI 269399950 MG/MLRxCUI 106781200 MG/MLRxCUI 106783 -
Dose form (SCDF) Oral Capsule RxCUI 437272No current FDA listingClinical drug / strength (SCD) 500 MGRxCUI 664732600 MGRxCUI 606971 -
Dose form (SCDF) Oral Tablet RxCUI 370532No current FDA listingClinical drug / strength (SCD) 600 MGRxCUI 429042
Look up RxCUI 197 in the RxCUI Atlas →
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
Acetylcysteine supply and shortage status
Whether Acetylcysteine is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
Acetylcysteine brand names
Acetylcysteine is sold under one brand name in the FDA directory — Acetadote. A brand and its generic contain the same active ingredient; the brand name belongs to one company's product.
Who makes Acetylcysteine: manufacturers and labelers
32 companies list Acetylcysteine products with the FDA. By number of product records, the largest are Fresenius Kabi USA, LLC, PharmaZell GmbH, American Regent, Inc.. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.
…and 8 more on the FDA NDC directory.
Acetylcysteine drug class (RxNorm)
Acetylcysteine belongs to the Antidote class.
Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.
Sources for this Acetylcysteine page
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How this page is built
HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Fresenius Kabi USA, LLC is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →